Position in RCUS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,668,552
+$798,921 QoQ
Shares Held
86,557
0.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#74
of 230 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. RCUS ranks #3 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
This page
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in RCUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,668,552 | 86,557 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,869,631 | 86,557 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,062,653 | 86,557 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,196,895 | 88,007 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $716,376 | 88,007 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $679,692 | 86,585 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,277,666 | 85,807 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,311,989 | 85,807 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,307,069 | 85,822 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,620,036 | 85,807 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,637,481 | 85,732 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,532,606 | 85,382 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $1,734,108 | 85,382 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $1,557,367 | 85,382 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $1,761,046 | 85,157 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,219,989 | 84,862 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,150,276 | 84,857 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,677,171 | 84,828 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $3,431,977 | 84,803 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,963,357 | 84,983 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,340,278 | 85,225 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,393,118 | 85,225 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,212,441 | 85,225 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,460,756 | 85,225 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,149,411 | 86,880 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,216,082 | 87,614 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||